BS
ALXN
Banco Santander’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-7,023
| Closed | -$804K | – | 409 |
|
2020
Q3 | $804K | Buy |
7,023
+4,755
| +210% | +$544K | 0.01% | 253 |
|
2020
Q2 | $255K | Buy |
+2,268
| New | +$255K | ﹤0.01% | 321 |
|
2020
Q1 | – | Sell |
-6,598
| Closed | -$714K | – | 467 |
|
2019
Q4 | $714K | Buy |
6,598
+761
| +13% | +$82.4K | 0.01% | 299 |
|
2019
Q3 | $572K | Buy |
5,837
+1,550
| +36% | +$152K | 0.01% | 303 |
|
2019
Q2 | $562K | Sell |
4,287
-28,706
| -87% | -$3.76M | 0.01% | 299 |
|
2019
Q1 | $4.46M | Hold |
32,993
| – | – | 0.05% | 145 |
|
2018
Q4 | $3.21M | Buy |
32,993
+1,293
| +4% | +$126K | 0.04% | 172 |
|
2018
Q3 | $4.41M | Sell |
31,700
-482,207
| -94% | -$67M | 0.05% | 160 |
|
2018
Q2 | $63.8M | Buy |
513,907
+1,119
| +0.2% | +$139K | 0.74% | 11 |
|
2018
Q1 | $57.2M | Buy |
512,788
+424,088
| +478% | +$47.3M | 0.67% | 21 |
|
2017
Q4 | $10.6M | Hold |
88,700
| – | – | 0.15% | 59 |
|
2017
Q3 | $12.4M | Buy |
+88,700
| New | +$12.4M | 0.21% | 62 |
|